Product review of Springer AdisInsight (sources - content and coverage)
Jinfo Article
12th June 2020
Abstract
In the second part of our product review of AdisInsight from Springer Nature, a database of international drug research offering a single access location for current evidence on drug developments and treatments, we look at its content. In particular, its five content sets; drugs, clinical trials, deals, safety reports and patents. We also find out about its extensive editorial process.
Note: Full review in Subscription Report (PDF)
Content Access
Does your organisation have a Jinfo Subscription?
Access to Jinfo Content and Community is available through a Jinfo Subscription.
"Yes"
Please sign in to MyJinfo here so that we can check your access to this item:
Or sign in via email:
Enter your email and we'll send you a magic link to sign you in automatically.
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Product review of Springer AdisInsight (sources - content and coverage)
- Link to this page
- View printable version
Related articles:
- Product review of Springer AdisInsight (value - help & training; competitors; development; pricing)
Tuesday, 16th June 2020 - Product review of Springer AdisInsight (technology - search & user interface; outputs & alerts; administration)
Monday, 15th June 2020 - Product review of Springer AdisInsight (key advantages; introduction; contact details)
Thursday, 11th June 2020
Related reports:
- Product review of Springer AdisInsight
Thursday, 11th June 2020